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Summary
What we know
•	 Rates of risky consumption of alcohol and other 
drugs (AOD) and related harms among Indigenous 
Australians are generally twice those in the non-
Indigenous population.
•	 High levels of AOD-related harm among Indigenous 
Australians are both a consequence of, and contribute 
to, the health and social gap between them and non-
Indigenous Australians.
•	 Reduction of harmful AOD use must include broad 
strategies to address the underlying social factors 
which predispose towards, or protect against, harmful 
use; and strategies specifically targeting harmful use 
itself.
•	 AOD-specific strategies should aim to prevent or 
minimise the uptake of harmful use; provide safe care 
for those who are intoxicated; provide treatment 
for those who are dependent; support those whose 
harmful AOD use has left them disabled or cognitively 
impaired; and support those whose lives are affected 
by others’ harmful AOD use. 
What works
•	 The National Drug Strategy Aboriginal and Torres Strait 
Islander Peoples Complementary Action Plan provides a 
comprehensive framework for the provision of AOD-
specific interventions, including supply, demand and 
harm reduction strategies.
•	 There is extensive national and international evidence 
for effective intervention and, although it is limited, 
the evidence from Indigenous studies is congruent 
with these broader findings.
•	 Effective supply reduction strategies include price 
controls, restrictions on trading hours, fewer alcohol 
outlets, dry community declarations, substitution of 
Opal fuel for unleaded petrol, and culturally sensitive 
enforcement of existing laws.
•	 Effective demand reduction strategies include early 
intervention, provision of alternatives to AOD use, 
various treatment modalities, and ongoing care to 
reduce relapse rates.
•	 Effective harm reduction strategies include provision 
of community patrols, sobering-up shelters, and 
needle and syringe exchange programs.
•	 Factors which facilitate the effective provision of AOD 
services to Indigenous Australians include Indigenous 
community control, adequate resourcing and support, 
and planned, comprehensive intervention.
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What doesn’t work
•	 Interventions designed for the non-Indigenous 
population that are imposed without local Indigenous 
community control and culturally appropriate adaptation.
•	 Local dry area bans (that is, location-specific as 
opposed to community-wide bans) are not effective in 
reducing AOD use and simply shift such use to other 
areas, often where there is greater risk of harm.
•	 Voluntary alcohol accords have limited effect.
•	 On their own, education and persuasion programs 
have limited impact. They need to be employed in 
conjunction with other interventions.
•	 Interventions which stigmatise AOD users are 
counter-productive.
•	 Interventions which focus upon dependent users, and 
ignore episodic ‘binge’ users, have limited impact.
•	 Barriers to effective service provision include short-term 
one-off funding, provision of services in isolation and 
failure to develop Indigenous capacity to provide services.
What we don’t know
•	 There is a paucity of regional and local level AOD use 
prevalence data that can enable better targeting of 
intervention and service provision.
•	 There are too few high-quality outcome and process 
evaluations of Indigenous-specific interventions, which 
can guide the enhancement of AOD interventions.
•	 Despite gaps in our knowledge, there is ample 
evidence to show what can be done to reduce AOD-
related harm. What is needed is the commitment to 
do it—with and not for Indigenous people.
The harmful use of 
alcohol and other drugs
The harmful use of AOD (that is, any use that impacts 
negatively on the health, social and emotional wellbeing 
of users themselves and others) is a significant public 
health problem for the Australian community as a whole 
and incurs significant economic costs. In this paper, we 
focus on one aspect of this wider problem and provide 
an overview of: 
•	 harmful AOD use within Indigenous communities
•	 its relationship to the health gap between Indigenous 
and non-Indigenous Australians
•	 strategies that are known to be effective in 
reducing harm
•	 the necessary conditions for such effectiveness.
The social and historical 
context
The health of individuals and populations is largely 
determined by social and economic factors, which 
can both protect against or increase the risk of ill 
health or harmful AOD use. A review of the evidence, 
conducted for the World Health Organization, found a 
clear link between socioeconomic deprivation and risk 
of dependence on alcohol, nicotine and other drugs 
(Wilkinson & Marmot 2003).
On all social indicators, Indigenous Australians are 
disadvantaged compared with non-Indigenous Australians 
(AIHW & ABS 2008; SCRGSP 2009; Vos et al. 2007). 
As among Indigenous populations elsewhere, this is 
a consequence of the historical and continuing impact 
of colonialism and dispossession, which has left many 
impoverished, marginalised, discriminated against, in 
a state of poor physical and mental health, and with 
inequitable access to necessary public and private 
services, particularly education, health and employment. 
Higher levels of harmful AOD use are one consequence 
of the trauma caused by this (Saggers & Gray 1998). In 
turn, higher levels further contribute to poor health 
status and social disruption. These associations, as well 
as evidence that higher levels of income, employment 
and participation in education are protective against 
harmful AOD use (AIHW & ABS 2008; Thomas et al. 
2008), indicate that it is necessary to address the 
underlying social determinants—to ‘close the gap’—as 
well as implementing interventions directly targeting 
AOD use itself.
Patterns of use and related 
harm
Surveys of AOD use are of varying quality and 
consistency and always underestimate actual 
consumption (Gray et al. 2010; Stockwell et al. 2004). 
However, they indicate that levels of harmful use 
among Indigenous Australians are about twice those 
in the non-Indigenous population.
Between 45% and 50% of Indigenous Australians 
report smoking tobacco compared to about 19% of 
non-Indigenous Australians. The proportion of those 
who do not currently drink alcohol is around 23% 
for Indigenous Australians compared with 17% for 
non-Indigenous Australians. 
Around 20% of non-Indigenous Australians consume 
alcohol in a manner that poses short-term risks to 
their health—usually in the form of heavy episodic 
consumption, pejoratively referred to as ‘binge drinking’. 
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In addition, a further 10% drink at levels which pose long-
term health risks. As a consequence of methodological 
issues relating to sampling and the questions posed, it 
is difficult to estimate levels of risky drinking among 
Indigenous Australians (Chikritzhs & Brady 2006; Gray 
et al. 2010). However, the available data suggest that 
the pattern of heavy episodic drinking is more marked 
among Indigenous Australians, and that the prevalence 
of consumption that poses both short- and long-term 
risks to health is about double that of the non-Indigenous 
population (Gray et al. 2010).
A smaller proportion of non-Indigenous Australians 
report recent use of cannabis (11%) or amphetamine-
type stimulants (3%) compared to about 22% and 7% 
respectively among Indigenous Australians. Use of 
other illicit drugs is estimated to be about 1.5 times 
higher in the Indigenous population and injecting of illicit 
drugs use is at least double. Use of prescription drugs 
for non-medical purposes is also significantly higher. 
Nationally, the use of volatile substances is geographically 
widespread but generally of low prevalence (about 5%), 
although inhalation of petrol is concentrated in some 
communities. In addition, polydrug use is common.
Evidence for changes in the prevalence of AOD use 
comes from a range of sources and, for a variety of 
reasons, must be treated with caution (ABS 2004, 2006; 
AIHW 2005, 2008; CDHSH 1996). However, they are 
broadly indicative and suggest that, over the past 15 
years or so, the gap in rates between the Indigenous 
and non-Indigenous populations has increased. Among 
non-Indigenous Australians between 1993 and 2007 the 
prevalence of tobacco smoking declined by about 30%; 
whereas between 1994 and 2008 among Indigenous 
Australians it declined by only about 7%. In the same 
time periods, the prevalence of alcohol use among 
non-Indigenous Australians increased by 14%; among 
Indigenous Australians by 24%. There was a 13% decline 
in the prevalence of cannabis use in the non-Indigenous 
population, but an increase of about 3% among 
Indigenous people. Despite a small baseline, there was 
an increase in the use of amphetamine-type stimulants of 
about 300% among Indigenous Australians compared to 
an 128% increase in the non-Indigenous population.
Data derived from the various national surveys provide 
a broad indication of the prevalence of Indigenous AOD 
use. However, we know from other sources (such as 
death rates attributable to alcohol and hospitalisations 
for various AOD-related conditions) that they conceal 
significant regional variation (Gray et al. 2010). The lack 
of published reliable data on such variation is a constraint 
on the better targeting of AOD interventions.
Higher levels of AOD use among Indigenous Australians 
are reflected in data on hospital admissions and deaths. 
They are hospitalised for tobacco-related illnesses 
at 3.6 times the rate of non-Indigenous Australians. 
Smoking accounts for 12% of the total burden of disease 
and 20% of deaths, compared to about 8% and 12% 
in the general population (AIHW & ABS 2008; Vos et al. 
2007). Indigenous Australian males are hospitalised 
for conditions, to which alcohol makes a significant 
contribution, at rates between 1.2 and 6.2 times those 
of non-Indigenous males, and Indigenous females at 
rates between 1.3 and 33.0 times greater (in the latter 
case for assault injuries) (AIHW & ABS 2008). Similarly, 
deaths from various alcohol-related causes are 5 to 19 
times greater than among non-Indigenous Australians 
(SCRGSP 2009).
Hospital admission rates of Indigenous people for 
conditions caused by drugs other than tobacco and 
alcohol are over twice those among non-Indigenous 
Australians. Illicit drugs have been estimated to cause 
3.4% of the burden of disease and 2.8% of deaths 
compared to 2.0% and 1.3% among the non-Indigenous 
population (AIHW & ABS 2008; Vos et al. 2007).
Many non-Indigenous Australians with AOD problems 
have co-occurring mental health and behavioural 
problems (Allsop 2008). Survey data indicate that 
Indigenous people are more than twice as likely as non-
Indigenous Australians to feel high or very high levels of 
psychological distress and are more likely to report also 
having an AOD problem (Garvey 2008; SCRGSP 2009).
As well as health problems, alcohol and other drugs 
are the cause of a wide range of social problems and 
contribute to high rates of Indigenous unemployment 
and incarceration (NIDAC 2009). They also have 
significant impacts on people other than users 
themselves. Of particular concern are the negative 
impacts of violent antisocial behaviour and parental 
AOD use on unborn children (fetal alcohol spectrum 
disorder—FASD) (O’Leary 2004), children and 
adolescents and the intergenerational impacts of 
these. Whether they use them or not, all Indigenous 
Australians are impacted upon by AOD in some way.
Strategies to address 
harmful use and their 
efficacy
As harmful AOD use is a complex, multi-causal 
phenomenon, addressing it requires a comprehensive 
approach, including strategies to:
•	 address the underlying social determinants
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•	 prevent or minimise the uptake of harmful use
•	 provide safe acute care for those who are intoxicated
•	 provide treatment for those who are dependent 
•	 support those whose harmful AOD use has left them 
disabled or cognitively impaired
•	 support those whose lives are affected by others’ 
harmful AOD use.
In the case of alcohol, it is important to note that much 
of the short-term harm (accidents, assaults, etc.) is a 
consequence of heavy episodic drinking, not of alcohol 
dependence per se. For this reason, interventions which 
focus largely on dependent persons will be limited in 
their impact.
A national policy approach for addressing the social 
determinants is provided by the ‘Closing the Gap’ 
framework agreed upon in 2008 and a framework for 
AOD-specific interventions by the National Drug Strategy 
Aboriginal and Torres Strait Islander Peoples Complementary 
Action Plan (FaHCSIA 2009; MCDS 2006). The latter is 
based on a harm minimisation approach which includes 
demand, supply and harm reduction strategies.
There is an extensive literature on the relative efficacy 
of strategies to reduce AOD-related harm (Babor et 
al. 2010; Gowing et al. 2001; Loxley et al. 2004; NDRI 
2007; Shand et al. 2003; Stockwell et al. 2005). However, 
among Indigenous Australians the number of well-
conducted evaluations remains limited. This does not 
mean that such interventions are not effective and, in the 
case of alcohol, Brady (1998) has prepared a useful guide 
to their implementation.
Supply reduction
There is a well-established positive relationship between 
the supply of AOD, levels of consumption and related 
harm (Babor 2010). Supply reduction strategies are 
those that aim ‘…to disrupt the production and supply 
of illicit drugs, and the control and regulation of licit 
substances’ (MCDS 2006). In most instances, such 
strategies have been applied to communities as a whole 
and it is important that they be implemented in a non-
discriminatory manner.
Price controls
The evidence demonstrates that increasing price is 
the most effective means of reducing consumption 
(Babor et al. 2010; Shibuya et al. 2003). In Australia, 
increases in taxation on tobacco products have been a 
major factor in the reduction of smoking (Scollo et al. 
2003). Evaluation of the Northern Territory’s ‘Living 
with Alcohol’ program demonstrated that a small 
additional levy on alcoholic beverages contributed to a 
significant reduction in consumption (Chikritzhs et al. 
2005). Recently, both the National Preventative Task 
Force and the Committee to review ‘Australia’s Future 
Taxation System’ recommended that a volumetric tax on 
alcohol be introduced to reduce alcohol-related harm 
and to cover its costs to the wider community (Henry 
et al. 2009; NPTF 2009). However, to protect the wine 
industry, this was rejected by the Australian Government 
(Rudd & Swan 2010). 
An indirect means of increasing the price of alcoholic 
beverages is banning the sale of wine in casks of more 
than 2 litres. This has the effect of taking the most 
inexpensive beverage off the local market, thus increasing 
the mean cost of alcoholic drinks with consequent 
reductions in consumption (Gray et al. 2000; NDRI 2007).
Trading hours
Reductions in the hours of trading for licensed premises 
are effective in reducing alcohol consumption and related 
harm. Such measures include reducing the hours of the 
day in which takeaway alcohol can be purchased and 
prohibiting the sale of full-strength beverages for on-
premises consumption before midday (NDRI 2007).
Outlet density
International evidence demonstrates that reducing the 
density of alcohol sales outlets is effective (Babor et 
al. 2010). However, this is not a measure that has been 
widely used in Australia. Yet, there have been cases in 
which community groups have successfully opposed 
the granting of additional licences on the basis of likely 
increase in harm.
Dry community declarations
Many remote Indigenous communities have themselves 
prohibited the consumption of alcohol within their 
boundaries—that is, declared themselves ‘dry’—often as 
a response to alcohol-related violence. Although there 
may be attempts to overturn them, overall the evidence 
suggests that such prohibitions result in reductions 
in alcohol-related harm (NDRI 2007). As part of the 
Northern Territory Emergency Response (NTER) 
(Commonwealth of Australia 2007), prohibitions were 
imposed on additional remote communities. There are 
no studies of the effectiveness or otherwise of these 
externally imposed prohibitions compared to voluntary 
impositions. However, we must learn from past mistakes 
and recognise that such impositions are likely to be 
regarded as paternalistic and resisted by Indigenous 
people.
It is sometimes asserted that the imposition of 
prohibitions as part of the NTER led to a substitution of 
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cannabis for alcohol. However, the evidence suggests that 
cannabis use was increasing before the implementation 
of the NTER (Gray 2010) and the international evidence 
demonstrates that there are no simple one-to-one 
substitutions of one type of psychoactive substance for 
another (Saffer & Chaloupka 1999).
Local dry area alcohol bans
Another form of prohibition has been ‘local dry area 
bans’ under which consumption is prohibited in specific 
locations within towns or cities. Such bans—often 
implicitly targeted at Indigenous people—include 
Northern Territory legislation banning consumption of 
alcohol within 2 kilometres of a licensed premise and 
in designated areas within towns or cities, such as Port 
Augusta and Adelaide in South Australia. However, the 
available evidence indicates that these are ineffective and 
simply move public drinking to adjacent areas—often 
where the risk of harm is greater (NDRI 2007).
Liquor licensing accords
Liquor licensing accords are agreements between 
licensees within a particular locality to voluntarily impose 
restrictions on themselves. These may, for example, 
include restrictions on the types of beverages sold, 
trading hours or discounting of beverages. Unlike many 
of the restrictions discussed in this section (which are 
imposed by regulatory authorities), these are not legally 
enforceable and, in the absence of enforcement, the 
evidence indicates that they are limited in effectiveness 
(NDRI 2007).
Controls on the availability of volatile 
substances
Supply reduction has been particularly successful in the 
reduction of petrol inhalation and related harms. The 
substitution of Opal (a non-sniffable fuel) for unleaded 
petrol in central Australian communities has led to 
significant reductions in petrol sniffing (SSCCA 2009). 
Refusal to sell volatile substances to minors and locking 
such substances away are also effective in reducing 
inhalation (d’Abbs & MacLean 2008; Gray et al. 2006). 
Other legislative measures and enforcement
In addition to the interventions discussed above, many of 
the most effective measures are already part of existing 
legislation. These include laws against the sale of tobacco 
and alcohol to minors, serving intoxicated persons, and 
driving under the influence of alcohol and other drugs. 
The effectiveness of such laws depends in large part upon 
enforcement (Loxley et al. 2004; NDRI 2007). However, 
enforcement needs to be sensitive to local social and 
cultural contexts (Gray et al. 2006). It should also be 
noted that in some communities there is a preference for 
enforcement by police from outside, as their roles are 
not compromised by various sociocultural obligations.
Demand reduction
Demand reduction strategies aim to both prevent the 
uptake of harmful AOD use and to minimise harm among 
those already using (MCDS 2006). Demand reduction 
embraces a wide range of strategies including health 
promotion, treatment and ongoing care.
Early intervention
Reduction of AOD consumption during pregnancy is 
effective in reducing harms to unborn infants. Total 
abstinence from tobacco smoking is recommended 
during pregnancy. However, the evidence suggests that in 
the prevention of FASD advocating total abstinence and 
(as with interventions more generally) stigmatising AOD 
users may be counter-productive. Rather, interventions 
should be non-stigmatising and broad-based, including  
‘… enhancing a woman’s diet, reducing physical and 
emotional abuse, and enhancing a woman’s current living 
status’ (Burd et al. 2003).
Positive family and developmental relationships in early 
childhood have been shown to be protective against 
harmful AOD use in later life (Toumbourou et al. 2005). 
Again, while there are few evaluated programs among 
Indigenous Australians, a number show clear promise 
(Sims et al. 2008).
Alternatives to AOD use
There is a broad range of preventive interventions, 
particularly targeted at young people. These include 
provision of alternatives to AOD use such as sporting 
and cultural activities, mentoring programs and programs 
to retain young people in school or facilitate employment 
for them. Although few of these have been evaluated in 
either Indigenous or non-Indigenous communities, many 
build upon factors known to be protective, and there are 
good theoretical grounds for their implementation (Gray 
et al. 2000; Loxley et al. 2004; Preuss & Brown 2006). 
However, recreational and cultural activities are often 
provided on an ad hoc basis with one-off funding (Gray et 
al. 2010). To be effective these interventions need to be 
sustained.
Education and persuasion
The evidence indicates that, on their own, health education 
and AOD awareness interventions have limited impact. 
For example, the effects of most school-based AOD 
education appear to be weak and short term. Similarly, 
there is evidence in the general population that mass 
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social marketing programs have had some impact on 
smoking, and to a lesser extent alcohol use, but, again, 
the impact is difficult to sustain (Babor et al. 2010; Loxley 
et al. 2004). Thus, while they have a role to play, it is 
important that these strategies not be used in isolation.
Treatment
Loosely, the term ‘treatment’ covers a broad range 
of interventions for AOD-related problems. These 
include screening, brief interventions, detoxification, 
various counselling approaches (including motivational 
interviewing and cognitive behavioural therapy),  
12-steps programs, and the provision of social and 
vocational skills. Some are generic while others are 
substance specific and include therapy to address 
underlying psychosocial trauma. Treatment programs 
are carried out in both community and residential 
settings, and focus on individuals and their families. In 
addition, effective pharmacotherapies are available for 
the treatment of nicotine, alcohol and opioid dependence 
(Gowing et al. 2001, Gray et al. 2008; Shand et al. 2003). 
Overall, the international literature shows that treatment 
for AOD problems is effective (Babor et al. 2010; 
Gowing et al. 2001; Shand et al. 2003).
Generally, residential treatment is not more effective 
than non-residential treatment (Babor et al. 2010). 
However, the evidence suggests that it is more effective 
for particular groups of clients including those ‘… with 
more severe deterioration, less social stability and 
a high risk of relapse’ (Shand et al. 2003). These are 
characteristics of many Indigenous clients and for them 
residential treatment may be the only practical option. 
Brady (2002) has provided an overview of Indigenous 
residential treatment programs, which includes the 
factors contributing to their efficacy.
Diversion to treatment
In the various state and territory jurisdictions, there is a 
range of programs aimed at either diverting both young 
people and adults who have committed AOD-related 
offences into treatment, or including treatment as part 
of the sentencing process (Pritchard et al. 2007; Siggins 
Miller Consultants 2003). Most of these programs focus 
on illicit drug use, although there are some which target 
alcohol and/or volatile substance use (such as those in the 
Northern Territory). 
As a consequence of eligibility criteria (such as exclusion 
of those committing violent offences) or lack of 
treatment options in many jurisdictions, Indigenous 
Australians generally have had less access to these 
diversion programs than non-Indigenous people. A 
review concluded that there is no strong evidence that 
such programs are effective in reducing AOD use and 
called for more rigorous evaluation of them (Pritchard 
et al. 2007). However, they have the potential to reduce 
the high numbers of Indigenous people in custody.
Ongoing care
While treatment is effective, AOD dependence is a 
chronic relapsing condition and it is not realistic to 
expect that one program of treatment will result in 
long-term abstinence or controlled use. For this reason, 
ongoing or follow-up care is essential and has been 
shown to reduce the frequency of relapse (McLellan 
2002). Unfortunately, however, there is a lack of such 
services for Indigenous Australians (Gray et al. 2010).
Harm reduction
Harm reduction strategies aim to reduce AOD-related 
harm to individuals and communities without necessarily 
reducing use (Loxley et al. 2004; MCDS 2006). The most 
common of these are community patrols, sobering-
up shelters and needle exchange programs. While 
not specifically targeted at AOD use, services such as 
women’s and youth shelters also perform harm reduction 
functions.
Community patrols and sobering-up shelters
There is little in the international literature on 
community patrols—a particularly Australian response 
to intoxication in remote communities. Patrols prevent 
intoxicated persons harming themselves or others by 
removing them to safe locations. Sobering-up shelters 
provide such safe locations and supervision of intoxicated 
people. There have been few specific evaluations of 
patrols and sobering-up shelters, but those that have 
been undertaken show they have community support and 
are effective in meeting their objectives (Blagg & Valuri 
2004; Brady et al. 2006; Gray et al. 2000).
Needle and syringe programs
Needle and syringe programs exchange used for new, 
clean needles and associated injecting equipment. Among 
the wider population, they have been shown to be 
particularly effective in reducing the spread of HIV and to 
a lesser extent hepatitis C (Southgate et al. 2003). There 
are few Indigenous-specific needle and syringe programs, 
although many community-controlled health services 
provide exchanges as part of their wider primary health 
care activities (Gray et al. 2010). There are no published 
evaluations of Indigenous-specific needle and syringe 
programs. However, based on the broader evidence, 
a recent review has recommended an expansion of 
these services for Indigenous Australians (Mitchell et al. 
forthcoming).
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Care for the physically and cognitively 
impaired
It is important to recognise that some dependent AOD 
users are either unwilling or—for reasons including living 
circumstances, and physical or cognitive impairment—
unable to engage in treatment. However, as with those 
in treatment, it is important they be linked into other 
health and social services that can address their needs 
and minimise the impact of their AOD use (Brady 2002; 
Stearne 2007).
Facilitators and barriers
There is good evidence for the efficacy of a broad range 
of AOD intervention strategies. However, ‘mainstream’ 
interventions developed for the non-Indigenous 
population cannot simply be imposed upon Indigenous 
communities. To be effective, such interventions need to 
be applied in a non-discriminatory manner, adapted so 
that they are appropriate to local cultures, and be subject 
to Indigenous community control. Efficacy depends 
crucially upon implementation and resourcing, and 
several reports identify factors which either facilitate or 
create barriers to effective intervention (Gray et al. 2010; 
Siggins Miller Consultants 2007; Strempel et al. 2004). 
Effective interventions should:
•	 have the support of, and be controlled by, local 
communities 
•	 be designed specifically for the needs of particular 
communities and subgroups within them 
•	 be culturally sensitive and appropriate
•	 have adequate resourcing and support 
•	 be resourced to cater for clients with complex needs
•	 provide ongoing care
•	 achieve an appropriate balance between broad-based 
and substance specific services
•	 be part of a planned, integrated set of interventions.
Barriers to the provision of effective interventions are 
often the converse of those that facilitate them, and 
include:
•	 short-term, one-off funding
•	 provision of services in isolation 
•	 failure to develop Indigenous capacity to deliver 
services—including failure to develop a suitably skilled 
workforce
•	 limited, up-to-date research and data.
There is a reasonably sound evidence base for the 
efficacy of particular interventions and the factors that 
contribute to them. However, there are significant gaps 
in the provision of services. The National Drug Strategy 
Aboriginal and Torres Strait Islander Peoples Complementary 
Action Plan made a commitment to the provision of ‘a 
range of holistic approaches from prevention through 
to treatment and continuing care that is locally available 
and accessible’ (MCDS 2006). However, in many regions 
of the country Indigenous people do not have access to 
such a range of services. Among the most prominent 
gaps are the lack of ongoing care for those completing 
treatment, treatment services for women and children, 
and services for those with co-occurring mental health 
problems. In addition, there is evidence of a lack of 
planning in service provision. There is also cause for 
concern about increasing contracting out of service 
provision for Indigenous people to non-Indigenous non-
government organisations (Gray et al. 2010).
Conclusion
High rates of AOD consumption and related harm 
are both a consequence of, and contribute to, the gap 
between Indigenous and non-Indigenous Australians. 
There is a variety of effective strategies available to 
address this problem. First, the underlying social 
determinants, in particular education and employment, 
must be addressed. Second, there is evidence of the 
effectiveness of a range of supply reduction (price 
controls, restrictions on hours of sale, enforcement 
of existing laws and regulations), demand reduction 
(alternatives to AOD use, health promotion, treatment, 
ongoing care), and harm reduction (community patrols, 
sobering-up shelters, needle and syringe programs) 
strategies. Third, Indigenous communities need to be 
provided with the full range of such services.
Importantly, interventions should be initiated by, or 
negotiated with, local communities and implemented 
in ways that are culturally safe. As interventions are 
likely to be more effective if delivered by Indigenous 
community-controlled organisations, they need to be 
given support to develop the capacity to do so. Where 
Indigenous communities lack capacity, partnering with 
non-Indigenous organisations to help build capacity can 
occur if there is an agreement for Indigenous people to 
take full control within an agreed timeframe.
While there is a need for more current data and 
evaluation of interventions, there is ample evidence to 
show what can be done to reduce AOD-related harm 
among Indigenous Australians. What is needed is the 
commitment to do it—with and not for Indigenous 
people.
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Abbreviations
AOD alcohol and other drugs
FASD fetal alcohol spectrum disorder
NTER  Northern Territory Emergency Response 
Terminology
Indigenous: ‘Aboriginal and Torres Strait Islander’ 
and ‘Indigenous’ are used interchangeably to refer to 
Australian Aboriginal and/or Torres Strait Islander 
peoples. The Closing the Gap Clearinghouse uses the 
term ‘Indigenous Australians’ to refer to Australia’s first 
people. This term refers to ‘Aboriginal Australians’ and 
‘Torres Strait Islander peoples’.
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